HER2 status and response to neoadjuvant anti-HER2 treatment among patients with breast cancer and Li-Fraumeni syndrome
European Journal of Cancer · 2024
DOI: 10.1016/j.ejca.2024.114307 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift European Journal of Cancer, 2024. Verfasst von Michele Bottosso und 11 weiteren Autor:innen. Beteiligte Einrichtung: INSERM Unit U981, Gustave Roussy Cancer Campus, Villejuif, France; Department of Surgery, Oncology and Gastroenterology, University of Padua, Italy. …. Hauptthemen laut MEDLINE: Erb-b2 Receptor Tyrosine Kinases, Neoadjuvant Therapy, Li-Fraumeni Syndrome, Breast Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 51 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- INSERM Unit U981, Gustave Roussy Cancer Campus, Villejuif, France; Department of Surgery, Oncology and Gastroenterology, University of Padua, Italy. Electronic address: michele.bottosso@iov.veneto.it.
- Medical Oncology Center, Hospital Sírio-Libanês, Brasília, DF, Brazil.
- INSERM Unit U981, Gustave Roussy Cancer Campus, Villejuif, France.
- Breast Surgery Department, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
- Gustave Roussy, Département de médecine oncologique, F-94805 Villejuif, France.
- Department of Translational Medicine, University of Piemonte Orientale (UPO), Novara, Italy; Medical Oncology, "Maggiore Della Carità" University Hospital, Novara, Italy.
Zitieren
APA
Bottosso, M., Sandoval, R. L., Verret, B., Polidorio, N., Caron, O., Gennari, A., Bychkovsky, B. L., Cahill, S. H., Achatz, M. I., Guarneri, V., André, F., & Garber, J. E. (2024). HER2 status and response to neoadjuvant anti-HER2 treatment among patients with breast cancer and Li-Fraumeni syndrome. European Journal of Cancer. https://doi.org/10.1016/j.ejca.2024.114307
Vancouver
Bottosso M, Sandoval RL, Verret B, Polidorio N, Caron O, Gennari A, et al. HER2 status and response to neoadjuvant anti-HER2 treatment among patients with breast cancer and Li-Fraumeni syndrome. European Journal of Cancer. 2024. doi:10.1016/j.ejca.2024.114307
BibTeX
@article{Bottosso2024,
author = {Bottosso, Michele and Sandoval, Renata L and Verret, Benjamin and Polidorio, Natalia and Caron, Olivier and Gennari, Alessandra and Bychkovsky, Brittany L and Cahill, Sophie H and Achatz, Maria I and Guarneri, Valentina and André, Fabrice and Garber, Judy E},
title = {HER2 status and response to neoadjuvant anti-HER2 treatment among patients with breast cancer and Li-Fraumeni syndrome},
journal = {European Journal of Cancer},
year = {2024},
doi = {10.1016/j.ejca.2024.114307}
}
EUVIMED